Christina is the associate editorial director of The American Journal of Managed Care® (AJMC®) and The American Journal of Accountable Care® (AJAC), and joined AJMC in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.
She has a BS in public health from Rutgers University. You can connect with Christina on LinkedIn.
5 Strategies From National Immunization Awareness Month to Boost Vaccination Rates
Several studies and commentaries published during National Immunization Awareness Month have addressed strategies to bring the vaccine coverage rate higher. Here are 5 promising tactics discussed this month for boosting immunization rates.
Report Analyzes Advantages, Drawbacks of Small Businesses' Health Benefits
A new report finds that small businesses in the US are offering health benefits that are competitive with those offered by larger employers, but that workers at the smallest companies tend to pay higher premium costs.
Predictive Tool Could Target Patients at Risk of Hypoglycemia-Related Utilization
Researchers have outlined a 6-item risk stratification tool that successfully predicted the likelihood that patients with diabetes will have a hypoglycemia-related emergency department visit or hospital admission.
MACRA Proposal Comment Period Draws Suggestions From Groups, Individual Providers
With the comment period now concluded, CMS has received nearly 1300 comments on its proposed amendments to the Quality Payment Program established by the Medicare Access and CHIP Reauthorization Act (MACRA).
Health Center Week Celebrated With HHS Grant As FQHC Staff Report Workplace Woes
As HHS celebrates National Health Center Week by announcing $105 million in grants for quality improvement, a study indicates that practice transformation may be taking a toll on satisfaction among clinicians and staff at some federally qualified health centers.
Cancer Drug Price Increases Cost Medicaid Millions in Extra Spending, Analysis Shows
An analysis by Kaiser Health News found that Medicaid incurred billions of dollars in extra spending as a result of price increases for hundreds of common drugs from 2015 to 2016, including decades-old branded drugs and generics used to treat cancer.
Prescribing Patterns Indicate Role of Physician Education in Controlling Opioid Epidemic
Researchers have highlighted physician education as a potential solution for the opioid epidemic, based on their findings that attending a top-ranked medical school is associated with writing far fewer opioid prescriptions.
NCI Researchers Discuss Prospects and Challenges of Treating Glioblastoma
Amidst news of Senator John McCain’s glioblastoma diagnosis, a recent discussion between 2 neuro-oncology researchers explored the reasons why this aggressive brain tumor is so difficult to manage, and outlined the ongoing investigations into possible therapies.
Study Finds Rising Insurer Approvals for Cancer Clinical Trials Since ACA
After the Affordable Care Act (ACA) required private insurers to pay the standard-of-care costs for patients participating in approved clinical trials, the rate of patients cleared by their insurer to take part in early-phase oncology trials has increased, a new study has found.